Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

There was encouraging news last week, that, at long last, deaths related to lung cancer are going down significantly. However, in this week's Moves in Medicine, we look at the new challenge: Why are ...

Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as polycyclic aromatic hydrocarbons (PAHs), damage DNA and trigger the mutations ...

The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...

The US Food and Drug Administration (FDA) has fast-tracked a promising new gene therapy, KB707, which is inhaled as a fine mist for the targeted treatment of advanced or metastatic non-small-cell lung ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best cancer stocks to invest in now. On February 23, Summit Therapeutics ...

Lung cancer has till recently, been associated by older adults who are chronic smokers, but recent statistics indicate a concerning increase in young adult cases among non-smokers. The increasing ...

The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Most people associate lung cancer primarily with smoking, but growing evidence suggests diet plays a more significant role than previously thought. While numerous foods help protect against cancer, ...